Although many investigators performed mutational analysis of large AML cohorts, limited number of studies previously assessed the prevalence of IDH1 and IDH2 mutations in Ph-negative MPNs [1, 10, 11, 15, 24]. Here, IDH1 is linked to acute myeloid leukemia.